QUVIVIQ
Identification of Quviviq
| No description |
Google image searchProduct monograph
Active ingredient
daridorexant (daridorexant hydrochloride), 50 MG
DIN: 02537443
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: IDORSIA PHARMACEUTICALS LTD
Date: 12-JUL-2023
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05C — HYPNOTICS AND SEDATIVES (ATC, ATC/DDD)
- N05CJ — Orexin receptor antagonists (ATC, ATC/DDD)
- N05CJ03 — DARIDOREXANT (ATC/DDD)
